Phagocytosis of Bordetella pertussis incubated with convalescent serum

Journal of Infectious Diseases

Volumn 187, Issue 10, 2003, Pages 1646-1653

  Mobberley Schuman, Paula S ^a   Connelly, Beverly ^b   Weiss, Alison A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE TOXIN; ADENYLATE CYCLASE TOXIN ANTIBODY; ADHESIN; BACTERIAL TOXIN; BACTERIUM ANTIBODY; HEMAGGLUTININ; HEMAGGLUTININ ANTIBODY; TOXIN ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ADHERENCE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; CONVALESCENCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFECTION RESISTANCE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; SERUM;

ADENYLATE CYCLASE TOXIN; ADOLESCENT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CONVALESCENCE; FEMALE; HEMAGGLUTININS; HUMANS; IMMUNE SERA; MALE; MUTATION; NEUTROPHILS; PHAGOCYTOSIS; TIME FACTORS; VIRULENCE; WHOOPING COUGH;

EID: 0037569240     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374741     Document Type: Article

References (22)

1. Zanardi L, Pascual FB, Bisgard K, Murphy T, Wharton M, Maurice E. Pertussis - United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002; 51:73-6.
2. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998; 16:1901-6.
3. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998; 16:1907-16.
4. Weiss AA, Hewlett EL, Myers GA, Falkow S. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J Infect Dis 1984; 150:219-22.
5. Lenz DH, Weingart CL, Weiss AA. Phagocytosed Bordetella pertussis fails to survive in human neutrophils. Infect Immun 2000; 68:956-9.
6. Confer DL, Eaton JW. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 1982; 217:948-50.
7. Weingart CL, Weiss AA. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect Immun 2000; 68:1735-9.
8. Weingart CL, Mobberley-Schuman PS, Hewlett EL, Gray MC, Weiss AA. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun 2000; 68:7152-5.
9. Weingart CL, Keitel WA, Edwards KM, Weiss AA. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect Immun 2000; 68:7175-9.
10. Weingart CL, Broitman-Maduro G, Dean G, Newman S, Peppler M, Weiss AA. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun 1999; 67:4264-7.
11. Weiss AA, Mobberley PS, Fernandez RC, Mink CM. Characterization of human bactericidal antibodies to Bordetella pertussis. Infect Immun 1999; 67:1424-31.
12. Meade BD, Deforest A, Edwards KM, et al. Description and evaluation of serologic assays used in a multicenter trial of a cellular pertussis vaccines. Pediatrics 1995;96:570-5.
13. Lee SJ, Gray MC, Guo L, Sebo P, Hewlett EL. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Infect Immun 1999;67:2090-5.
14. Betsou F, Sebo P, Guiso N. CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun 1993; 61:3583-9.
15. Betsou F, Sebo P, Guiso N. The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun 1995; 63:3309-15.
16. Hormozi K, Parton R, Coote J. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice. FEMS Immunol Med Microbiol 1999; 23:273-82.
17. Zaretzky FR, Gray MC, Hewlett EL. Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin-filamentous hemagglutinin interaction. Mol Microbiol 2002; 45: 1589-98.
18. Weiss AA, Hewlett EL, Myers GA, Falkow S. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun 1983; 42:33-41.
19. Katada T, Ui M. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Natl Acad Sci USA 1982; 79:3129-33.
20. Schmidt G, Goehring UM, Schirmer J, Lerm M, Aktories K. Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for rho GTPases. J Biol Chem 1999; 274:31875-81.
21. Abramson T, Kedem H, Relman DA. Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin. Infect Immun 2001; 69:2650-8.
22. McGuirk P, Mills KH. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol 2000; 30:415-22.